Inflexal V

a virosome-based trivalent influenza vaccine, has been shown to be highly immunogenic and well tolerated in children, young adults, and the elderly

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Amicizia, Daniela: 1 article (01/2013)
2.	Gasparini, Roberto: 1 article (01/2013)
3.	Lai, Piero Luigi: 1 article (01/2013)
4.	Panatto, Donatella: 1 article (01/2013)
5.	Rossi, Stefania: 1 article (01/2013)
6.	Asenjo, M A: 1 article (05/2009)
7.	Domínguez, A: 1 article (05/2009)
8.	Garrido, P: 1 article (05/2009)
9.	Ibáñez, D: 1 article (05/2009)
10.	Navas, E: 1 article (05/2009)

Related Diseases

1.	Human Influenza (Influenza) 01/01/2013 - "Our study is the first to provide information on the effectiveness of Inflexal V (®) in terms of reducing hospitalizations for influenza or pneumonia in the elderly, and demonstrates that this vaccine yields a high degree of protection and that its use would generate considerable saving for the National Health Service." 01/01/2013 - "Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study." 05/26/2009 - "Taking the results of a prospective cohort study by our group that evaluated the effectiveness of the inactivated subunit virosomal influenza vaccine (Inflexal V), Crucell-Berna) in the prevention of influenza-related diseases and the reduction of its negative economic consequences, the economic costs and benefits for the family of vaccinating a theoretical cohort of 1000 healthy children aged 3-14 years with no risk factors with one dose of vaccine during the yearly health examination were quantiified. "
2.	Pneumonia (Pneumonitis) 01/01/2013 - "Our study is the first to provide information on the effectiveness of Inflexal V (®) in terms of reducing hospitalizations for influenza or pneumonia in the elderly, and demonstrates that this vaccine yields a high degree of protection and that its use would generate considerable saving for the National Health Service." 01/01/2013 - "Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study."
3.	Egg Hypersensitivity (Egg Allergy) 08/26/2008 - "The results showed the safety of the administration, and demonstrated that Inflexal V can be safely given without performing a vaccine skin test in children with any kind of egg allergy." 08/26/2008 - "In order to evaluate whether the virosomal adjuvanted influenza vaccine that has been shown to have the lowest egg protein content (Inflexal V, Berna Biotech) could be administered to children with even severe egg allergy without any risk of allergic reactions, we used epicutaneous skin testing with the undiluted vaccine in 88 asthmatic children (44 with and 44 without egg allergy), none of whom had a positive response. "
4.	Hypersensitivity (Allergy) 08/26/2008 - "In order to evaluate whether the virosomal adjuvanted influenza vaccine that has been shown to have the lowest egg protein content (Inflexal V, Berna Biotech) could be administered to children with even severe egg allergy without any risk of allergic reactions, we used epicutaneous skin testing with the undiluted vaccine in 88 asthmatic children (44 with and 44 without egg allergy), none of whom had a positive response. "

Related Drugs and Biologics

1.	Vaccines
2.	Influenza Vaccines (Influenza Vaccine)
3.	Egg Proteins